CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 32 enrolled
Drug / intervention
Tisseel fibrin adhesivedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00344201
NCT00344201Phase 1Completed

Assessment of Fibrin Glue in Pterygium Surgery and Other Forms of Ocular Surface Reconstruction

Singapore National Eye Centre·interventional·Posted Jun 26, 2006·Updated May 12, 2010

In Brief

A Phase 1 clinical trial evaluating Tisseel fibrin adhesive for Pterygium and Ocular Surface Cicatrizing Diseases. Completed, enrolled 32 participants across 1 site.

Detailed Summary

Tisseel fibrin adhesive has been used extensively in many forms of surgery. Its use in eye surgery has been relatively recent. A few studies recently showed it was effective in securing conjunctival grafts in pterygium surgery, and in securing wounds after glaucoma and squint surgery. We sought to confirm its effectiveness in pterygium surgery, as well as prove its effectiveness in securing other material to the ocular surface such as amniotic membrane. Our hypothesis is that fibrin adhesive is effective in securing various types of material to the ocular surface for a sufficient length of time to allow adequate healing before it is absorbed and degraded.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSingapore

Timeline

Phase 1CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 26, 2006
Enrollment StartNov 1, 2004
Primary CompletionJan 1, 2007
Study CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 20.0 years ago

Interventions

Tisseel fibrin adhesivedevice

Intraoperative application to scleral bed and graft